- Summary
- Price Reports
- Price History
- Add To Your Stocklist
- View your Stocklist
- Basic Chart
- Interactive Chart
- Headlines
- Company Snapshot
- Summary Reports
- Free Annual Report
- Estimate Snapshot
- Estimate Report
- Mobile Quote
- Real-Time Quote
- Streaming Quote
|
Alexza Pharmaceuticals | Company Snapshot
-
![]()
-
-
-
Vol:
-
Last Trade:
|
ALEXZA PHARMACEUTICALS
Alexza Pharmaceuticals is an emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The Company's technology, the Staccato system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience.
|
|
| Symbol: |
ALXA |
| Exchange(s): |
Nasdaq Stock Market |
| Industry: |
Consumer Products (Biotechnology & Pharmaceuticals) |
| 5-Star Rating: |
 |
|
ANNUAL FINANCIALS
|
|
|
Dec 31, 2008
12 Months
us$
|
Dec 31, 2007
12 Months
us$
|
Dec 31, 2006
12 Months
us$
|
3Yr.
Growth
% Change
|
|
Total Revenue ($000):
|
480
|
N/A
|
1,020
|
-40.07
|
|
Earnings before Interest & Tax ($000):
|
-76,110
|
-54,910
|
-42,750
|
N/A
|
|
Profit/Loss ($000):
|
-58,450
|
-45,110
|
-41,800
|
N/A
|
|
Earnings per Share:
|
-1.81
|
-1.58
|
-2.13
|
N/A
|
|
Total Assets ($000):
|
84,630
|
149,120
|
105,760
|
21.32
|
|
Dividends Per Share
|
0.00
|
0.00
|
0.00
|
|
|
Return on Com. Equity:
|
-106.58
|
-71.74
|
339.70
|
|
|
Employees:
|
N/A
|
N/A
|
N/A
|
|
|
|
|
|
Trailing 12 Month Results
|
|
|
12 Months ended
Sep 30, 2009,us$
|
12 Months ended
Sep 30, 2008,us$
|
%Change
|
|
Total Revenue ($000):
|
9,930
|
N/A
|
N/A
|
|
Profit/Loss ($000):
|
-98,900
|
-56,590
|
-74.77
|
|
Earnings per Share:
|
-2.75
|
-1.77
|
-55.37
|
|
Dividends Per Share
|
0.00
|
0.00
|
|
Number of Shares:
|
33,250,000
|
32,600,000
|
|
|
|
|
COMPANY INFORMATION
|
| Incorporation: |
United States |
| |
| Securities: |
ALXA-Q
|
|
| |
|
|
| |
|
|
Financial data is provided by Zacks Investment Research.
| |
All information on this site is compiled by CTVglobemedia Publishing Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, CTVglobemedia Publishing Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor.
Copyright © 2009 CTVglobemedia Publishing Inc. All rights reserved.
|
|
|
